Autoinflammatory Syndrome with Immunodeficiency: A Patient Guide
At a Glance
Autoinflammatory syndrome with immunodeficiency causes both excessive inflammation and reduced protection against infections. Care focuses on identifying the inherited or acquired subtype and balancing anti-inflammatory treatment with immune support, infection prevention, and regular monitoring.
Living with an autoinflammatory syndrome with immunodeficiency means navigating a rare and complex medical landscape where the immune system is simultaneously overactive and underactive. In a healthy system, the immune branches work in harmony to identify and eliminate threats while remaining quiet when the body is safe. In these conditions, that balance is broken: one part of the system is “stuck on,” causing the body to attack its own tissues with heat and swelling, while another part is “stuck off,” leaving it unable to defend against common germs [1][2]. (Note: This is a helpful teaching metaphor, though the specific immune defects vary widely by subtype.)
This diagnosis is an umbrella term within the broader field of Inborn Errors of Immunity (IEI). It encompasses several distinct, rare conditions where a single molecular “glitch” disrupts multiple immune pathways. These include inherited germline conditions that typically begin in childhood, such as HA20, APLAID, and HOIL-1 deficiency, as well as acquired somatic conditions like VEXAS syndrome, which usually appears in older adults [3][4]. Because these conditions are so heterogeneous, identifying the specific genetic mutation or likely subtype is a critical step in care, as it helps doctors move away from broad treatments toward targeted therapies that address your unique biological needs [5][6]. However, a negative or inconclusive genetic test does not exclude clinically significant disease.
Managing this dual-nature condition requires a delicate and ongoing balancing act. Treatment often involves using sophisticated medications to quiet the overactive inflammation while simultaneously using protective measures—like antibody infusions or preventative antibiotics—to bolster the underactive side of the immune system [6][7]. Because these diseases can affect the skin, blood, joints, and internal organs, your care is best managed by a multidisciplinary team of specialists who communicate regularly to adjust your plan as your needs change.
Long-term health depends on consistent monitoring to stay ahead of potential complications. This involves regular blood work to track inflammatory markers and immune cell counts, as well as specialized screenings tailored to your specific organ risks or changes in the bone marrow [5][8]. While the path can feel unpredictable, a clear diagnostic framework and a specialized care team provide the foundation needed to manage symptoms effectively and maintain a high quality of life [9][10].
In this guide
6 chapters
Understanding Your Diagnosis: Autoinflammatory Syndrome with Immunodeficiency
Learn what autoinflammatory syndrome with immunodeficiency means, including common subtypes, symptoms, genetic testing, infection risks, and specialist care.
Symptoms, Red Flags, and When to Seek Urgent Care
Learn which symptoms of autoinflammatory syndrome with immunodeficiency need emergency care, same-day review, including infection, sepsis, HLH, and MAS signs.
The Science of the System: Biological Mechanisms and Subtypes
Learn how autoinflammatory syndromes with immunodeficiency affect innate and adaptive immunity, including NF-kB, inflammasome pathways, HA20, APLAID, and VEXAS.
The Path to Certainty: Diagnosis and Your Lab Results
Learn how autoinflammatory IEI is diagnosed through CBC, inflammation tests, immune studies, genetic testing, and VEXAS UBA1 testing, with lab trends over time.
The Balancing Act: Treatment Strategies and Safety
Learn how to balance inflammation and infection risk in IEI with autoinflammation, including steroids, biologics, IVIG, prophylaxis, and transplant options.
The Long View: Building Your Care Team and Managing Your Future
Learn how to build a care team and plan long-term monitoring for IEI with autoinflammation, including VEXAS, HOIL-1 deficiency, and infection prevention.
Common questions in this guide
What is autoinflammatory syndrome with immunodeficiency?
Which conditions can fall under this diagnosis?
Can I still have this condition if genetic testing is negative?
How is autoinflammatory syndrome with immunodeficiency treated?
What monitoring is needed over time?
Get notified when new evidence is published on autoinflammatory syndrome with immunodeficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Autoinflammatory Diseases: A Review.
An J, Marwaha A, Laxer RM
The Journal of rheumatology 2024; (51(9)):848-861 doi:10.3899/jrheum.2023-1209.
PMID: 38879186 - 2
Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.
Zilberman-Rudenko J, Shawver LM, Wessel AW, et al.
Proceedings of the National Academy of Sciences of the United States of America 2016; (113(6)):1612-7 doi:10.1073/pnas.1518163113.
PMID: 26802121 - 3
Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment.
Yu MP, Xu XS, Zhou Q, et al.
World journal of pediatrics : WJP 2020; (16(6)):575-584 doi:10.1007/s12519-019-00288-6.
PMID: 31587140 - 4
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
Beck DB, Ferrada MA, Sikora KA, et al.
The New England journal of medicine 2020; (383(27)):2628-2638 doi:10.1056/NEJMoa2026834.
PMID: 33108101 - 5
How I Treat: Haploinsufficiency of A20.
Li J, Zhou JY, Carpio Tumba M, et al.
Journal of human immunity 2026; (2(4)):e20250138 doi:10.70962/jhi.20250138.
PMID: 42169681 - 6
Immunodeficiency: Overview of primary immune regulatory disorders (PIRDs).
Nelson CS, Baloh CH
Allergy and asthma proceedings 2024; (45(5)):332-339 doi:10.2500/aap.2024.45.240070.
PMID: 39294916 - 7
Guardians of Immunity: Advances in Primary Immunodeficiency Disorders and Management.
Peddi NC, Vuppalapati S, Sreenivasulu H, et al.
Cureus 2023; (15(9)):e44865 doi:10.7759/cureus.44865.
PMID: 37809154 - 8
VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge.
Kreutzinger V, Pankow A, Boyadzhieva Z, et al.
Journal of clinical medicine 2024; (13(4)) doi:10.3390/jcm13041049.
PMID: 38398362 - 9
Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey.
Shiraki M, Kadowaki S, Miwa Y, et al.
Frontiers in immunology 2025; (16()):1548042 doi:10.3389/fimmu.2025.1548042.
PMID: 40574834 - 10
Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.
Lawrence MG, Kim VHD, Orange JS, Scherzer R
The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.
PMID: 42447994
This guide is for educational purposes and does not replace medical advice. Your immunology and specialist care team should interpret genetic results, infection risks, and treatment choices for your individual situation.